1987
DOI: 10.1007/bf01800365
|View full text |Cite
|
Sign up to set email alerts
|

Lesch‐Nyhan syndrome and its pathogenesis: Purine concentrations in plasma and urine with metabolite profiles in CSF

Abstract: Purine metabolism in the Lesch-Nyhan syndrome has been re-examined in 10 patients. Hypoxanthine and xanthine concentrations in plasma and CSF and urinary excretion have been studied, on and off allopurinol treatment, using high performance liquid chromatographic methods. Accumulation of the substrate, hypoxanthine, of the missing hypoxanthine guanine phosphoribosyltransferase (HPRT) enzyme, is more marked in urine and in CSF than in plasma. The greater increase in CSF is consistent with the most metabolically … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
20
0

Year Published

1989
1989
2015
2015

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(24 citation statements)
references
References 48 publications
2
20
0
Order By: Relevance
“…The genetic defect of recycling hypoxanthine and guanine leads to the metabolic and neurological hallmarks of the disease; i.e., hyperuricemia, dystonia, and above all, the severely aberrant neurobehavioral effect of self-mutilation associated with severe basal ganglia dopamine (DA) depletion and defective DA uptake in both the human LND patients and in the HPRT knockout mouse. 1,2 The mechanisms responsible for the central nervous system (CNS) disorder are poorly understood. Molecular genetic studies of HPRT deficiency in the mouse knockout model and in human patients with LND have revealed few robust clues to the development of the neurological phenotype.…”
Section: Introductionmentioning
confidence: 99%
“…The genetic defect of recycling hypoxanthine and guanine leads to the metabolic and neurological hallmarks of the disease; i.e., hyperuricemia, dystonia, and above all, the severely aberrant neurobehavioral effect of self-mutilation associated with severe basal ganglia dopamine (DA) depletion and defective DA uptake in both the human LND patients and in the HPRT knockout mouse. 1,2 The mechanisms responsible for the central nervous system (CNS) disorder are poorly understood. Molecular genetic studies of HPRT deficiency in the mouse knockout model and in human patients with LND have revealed few robust clues to the development of the neurological phenotype.…”
Section: Introductionmentioning
confidence: 99%
“…The cause of this profoundly debilitating disease remains unknown. A common factor in LNS is that patients exhibit a characteristically raised level of hypoxanthine in plasma (Rosenbloom et al, 1967;Harkness et al, 1988;Puig and Mateos, 1993), urine (Sweetman, 1968;Harkness et al, 1988), and cerebrospinal fluid (Rosenbloom et al, 1967;Sweetman, 1968;Harkness et al, 1988).…”
mentioning
confidence: 98%
“…This view has found support by evidence that hypoxanthine-related metabolites accumulate to a greater degree than guanine-related metabolites, implying HGprt has a more biologically important role in recycling hypoxanthine than guanine (Sweetman and Nyhan 1970; Harkness et al 1988). Conversely, some studies suggest Gprt to be more relevant.…”
Section: Discussionmentioning
confidence: 97%